MedPath

Treatment protocol for acute promyelocytic leukemia FBMTG APL2017

Not Applicable
Recruiting
Conditions
acute promyelocytic leukemia
Registration Number
JPRN-UMIN000025044
Lead Sponsor
FBMTG
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

1. The case having double cancers 2. The case with an infectious disease having difficulty with control 3. The case with a severe mental disorder 4. The pregnancy or breast-feeding woman 5. The case that the medical attendant judged to be inappropriate

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
3 years disease-free survival
Secondary Outcome Measures
NameTimeMethod
5 years disease free survival CR rate Perfection rate of protocol regimen treatment-related toxicities Incidence rate of differentiation syndrome Frequency of additional administration of idarubicune Frequency of mutation in PML-RARA fusion gene and its influence for therapy efficacy
© Copyright 2025. All Rights Reserved by MedPath